2024-08-29T06:09:08-05:00 2023-12-31 390859910 BAKER TILLY ADVISORY GROUP LP 1570 FRUITVILLE PIKE SUITE 400 LANCASTER PA 17601 990 2023-01-01 223369741 INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH INTE 6095864981 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 ROBERT ABBOTT CEO & EXECUTIVE DIRECTOR 6095864981 2024-08-19 1 1 KERRI N BOGDA CPA P00760402 7177404863 2024-08-19 2023 2024-08-08 14:25:15Z ROBERT ABBOTT 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 31446481 0 X WWW.ISPOR.ORG X 1995 NJ PROMOTE GLOBAL HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING 13 12 65 1300 21800 11437 40000 25000 14205222 18800930 157836 -402340 189942 60171 14593000 18483761 0 0 0 0 6900605 7367146 0 0 0 8256369 9860751 15156974 17227897 -563974 1255864 23939884 27237931 4053006 2891022 19886878 24346909 X THE MISSION OF INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH (ISPOR) IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. 0 0 14188007 0 18779130 ISPOR IS A NON-PROFIT GLOBAL SCIENTIFIC AND EDUCATIONAL ORGANIZATION WITH APPROXIMATELY 9,296 MEMBERS, WHO ARE INVOLVED IN HEALTHCARE OUTCOMES RESEARCH (INCLUDING CLINICAL, ECONOMIC AND PATIENT-REPORTED OUTCOMES) OF HEALTH TECHNOLOGIES (DRUGS, DEVICES, DIAGNOSTICS) AND SERVICES OR THE USE OF OUTCOMES RESEARCH IN HEALTHCARE DECISIONS. THE MISSION OF ISPOR IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. ISPOR IS FUNDED THROUGH ITS MEETINGS, TRAINING COURSES AND MEMBERSHIP DUES. THROUGH ITS MULTIPLE MEETINGS EACH YEAR, ISPOR PROVIDES A FORUM TO FACILITATE THE INTERCHANGE OF SCIENTIFIC KNOWLEDGE IN PHARMACOECONOMICS /HEALTH ECONOMICS AND OUTCOMES RESEARCH, HEALTH POLICY AND THE USE OF THIS RESEARCH IN HEALTHCARE DECISIONS.ISPOR PUBLISHES TWO SCIENTIFIC JOURNALS, ONE HEOR NEWS MAGAZINE, AND FOUR ELECTRONIC NEWSLETTERS. ISPOR DEVELOPS CONSENSUS DOCUMENTS (GOOD PRACTICES/GUIDELINES) ON OUTCOMES RESEARCH METHODS OR USE OF THIS RESEARCH IN HEALTHCARE DECISIONS. ISPOR FOSTERS EDUCATION AND THE DEVELOPMENT OF OUTCOMES RESEARCH AT THE LOCAL LEVEL WITH ITS REGIONAL CHAPTERS AND STUDENT CHAPTERS GLOBALLY TO PROMOTE THE SCIENCE OF PHARMACOECONOMICS/HEALTH ECONOMICS AND HEALTH OUTCOMES RESEARCH WORLDWIDE. IN 2023, ISPOR HOSTED THREE IN-PERSON CONFERENCES: THE INTERNATIONAL CONFERENCE AND REAL-WORLD EVIDENCE SUMMIT IN BOSTON, AND THE EUROPEAN CONFERENCE IN COPENHAGEN, FEATURING OVER 5,200 SCIENTIFIC PRESENTATIONS. WE ALSO PUBLISHED 3,778 PAGES OF OUTCOMES RESEARCH AND HEALTH POLICY PAPERS IN OUR JOURNALSVALUE IN HEALTH, VALUE IN HEALTH REGIONAL ISSUES, AND VALUE & OUTCOMES SPOTLIGHT.OUR GLOBAL REACH IS EVIDENT IN OUR 7,775 MEMBERS FROM 99 COUNTRIES, 136 STUDENT CHAPTERS, AND 84 REGIONAL CHAPTERS. THROUGH ISPOR TASK FORCES, COUNCILS, AND SPECIAL INTEREST GROUPS, ISPOR ALSO DEVELOPS CONSENSUS GUIDELINES ON OUTCOMES RESEARCH METHODS AND THE APPLICATION OF THIS RESEARCH IN HEALTHCARE DECISIONS. OUR TOOLS FOR RESEARCHERS, SUCH AS THE GOOD PRACTICES FOR OUTCOMES RESEARCH, ARE WIDELY UTILIZED, WITH OVER 1,000,000 DOWNLOADS ANNUALLY, AND OUR WEB-BASED DATABASE CONTAINS OVER 74,000 RESEARCH PRESENTATIONS FROM ISPOR MEETINGS. THROUGH THESE EFFORTS, ISPOR FOSTERS THE EDUCATION AND DEVELOPMENT OF OUTCOMES RESEARCH WORLDWIDE. 14188007 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 73 0 65 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 13 12 0 0 0 0 1 1 0 1 1 0 1 1 0 1 1 1 1 1 1 0 0 NJ X JILL CHEN 6095864981 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 NANCY S BERG CEO & EXECUTIVE DIRECTOR 40.00 0.00 X X 257968 0 20944 JAN ELIAS HANSON PHD PAST PRESIDENT (SINCE JULY 2023) 2.00 0.00 X X 0 0 0 BRIAN O'ROURKE PRESIDENT (SINCE JULY 2023) 2.00 0.00 X X 0 0 0 SEAN SULLIVAN MSC PHD TREASURER 2.00 0.00 X X 0 0 0 DAVID THOMPSON PHD DIRECTOR (UNTIL 6/30/23) 2.00 0.00 X 0 0 0 EBERECHUKWU ONUKWUGHA MS PHD PRESIDENT-ELECT (SINCE JULY 2023) 2.00 0.00 X X 0 0 0 BETH DEVINE PHD DIRECTOR 2.00 0.00 X 0 0 0 MARLENE GYLDMARK MPHIL DIRECTOR 2.00 0.00 X 0 0 0 ANDREA MANCA MSC PHD DIRECTOR 2.00 0.00 X 0 0 0 DONG-CHURL SUH PHD DIRECTOR 2.00 0.00 X 0 0 0 LOTTE STEUTEN MPHIL DIRECTOR (UNTIL 6/30/23) 2.00 0.00 X 0 0 0 DALIA DAWOUD PHD DIRECTOR 2.00 0.00 X 0 0 0 AMY K O'SULLIVAN PHD DIRECTOR 2.00 0.00 X 0 0 0 LUCINDA ORSINI DPM MPH DIRECTOR 2.00 0.00 X 0 0 0 ISAO KAME PRESIDENT TO 7/1/23 THEN PAST PRESIDENT 2.00 0.00 X 0 0 0 SUSAN CAPON CHIEF OPERATING OFFICER 40.00 0.00 X 380503 0 30305 JILL CHEN DIRECTOR, FINANCE AND ACCOUNTING 40.00 0.00 X 155317 0 42423 ELIZABETH LANE CHIEF MARKETING OFFICER 40.00 0.00 X 215462 0 25527 LAURA PIZZI CHIEF SCIENCE OFFICER 40.00 0.00 X 300058 0 56881 PAUL WONG DIRECTOR, GLOBAL EVENTS 40.00 0.00 X 197764 0 11866 JENNIFER OLSEN-CASILLAS DIRECTOR, MEMBER ENGAGEMENT 40.00 0.00 X 199150 0 34540 MICHELLE ROVNER DIRECTOR, MARKETING 40.00 0.00 X 190242 0 34005 1896464 0 256491 19 0 1 0 FREEMAN 14221 DALLAS PARKWAY DALLAS TX 75254 AUDIO VISUAL 574299 LEVY PREMIUM FOOD SERVICE 415 SUMMER STREET BOSTON MA 02210 CATERING AND SERVICE 506089 VENABLE LLP PO BOX 62727 BALTIMORE MD 212642727 LEGAL SERVICES 387635 TAFT COMMUNICATIONS LLC 35 CLARK STREET SUITE 101 TRENTON NJ 08611 MARKETING/COMMUNICATION 313815 RICHARD J WILLKE 11622 CHANNEL FRONT CT SODDY DAISY TN 37379 SCIENTIFIC CONSULTING 298282 13 25000 25000 MEETING REVENUE 611430 15339562 15339562 EBULLETIN/TECH JOURNAL REVENUE 541900 1514671 1492871 21800 MEMBER SERVICES 611430 1294624 1294624 EDUCATION AND SCIENTIFIC REVENUE 541900 652073 652073 18800930 556459 556459 152298 96447 55851 55851 55851 11907474 12866273 -958799 -958799 -958799 WIRE TRANSFER FEES 900099 4320 4320 4320 18483761 18779130 21800 -342169 887460 663364 224096 5144095 3845140 1298955 233080 174224 58856 484072 361837 122235 618439 462274 156165 324755 312382 12373 222012 213553 8459 77493 77493 717728 690383 27345 1096366 819518 276848 96447 72093 24354 4135001 4135001 272933 204014 68919 46731 34931 11800 OTHER COMMUNICATION EXP 975753 729362 246391 JOURNAL/EDITORIAL 609449 609449 STAFF DEVELOPMENT 230247 172106 58141 BOARD/COMMITTEE EXPENSE 185034 181473 3561 870802 506903 363899 17227897 14188007 3039890 0 2602648 2187171 741395 625004 1346131 950871 307497 502442 4578045 1771358 2967182 2806687 15975031 20165756 23939884 27237931 1966626 1422347 2078990 1461285 7390 7390 4053006 2891022 X 19886878 24346909 19886878 24346909 23939884 27237931 1255864 3204167 0 X 0 1 X 1 0 X 210000 105000 35000 40000 25000 415000 15903323 4601894 5787986 14193622 18779130 59265955 16113323 4706894 5822986 14233622 18804130 59680955 0 0 0 59680955 402812 398597 445058 499411 708757 2454635 402812 398597 445058 499411 708757 2454635 7372 2381 1500 602 11437 23292 9243204 19494 127527 4320 9394545 16523507 14351076 6289038 14861162 19528644 71553427 0.83410 0.83090 0.03430 0.03070 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: INSURANCE PROCEEDS - 2020 AMOUNT: $ 9,243,204. BAD DEBT RECOVERY - 2021 AMOUNT: $ 19,494. STRATEGIC SPONSORSHIP - 2022 AMOUNT: $ 15,000. WIRE TRANSFER FEE - 2022 AMOUNT: $ 18,773. 2023 AMOUNT: $ 4,320. REBATES AND COMMISSIONS - 2022 AMOUNT: $ 93,754. 400000 400000 2579292 783366 1795926 1598753 987992 610761 2806687 SECURITY DEPOSIT 7390 7390 X 21610435 3204167 -77493 3126674 18483761 0 18483761 17150404 0 17150404 77493 77493 17227897 PART X, LINE 2: ISPOR IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). HOWEVER, INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO ISPOR'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. ISPOR FOLLOWS THE INCOME TAX STANDARD FOR UNCERTAIN TAX POSITIONS. ISPOR BELIEVES THERE ARE NO UNCERTAIN TAX POSITIONS THAT ARE REQUIRED TO BE DISCLOSED IN THE CONSOLIDATED FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT FEES -77,493. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT FEES 77,493. EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES ANNUAL EUROPEAN MEETING 2337171 0 0 0 0 0 0 2337171 0 2337171 0 0 0 0 0 0 X X X X 0 0 0 0 0 0 0 1 0 SUSAN CAPON CHIEF OPERATING OFFICER 254967 0 125536 0 0 0 19800 0 10505 0 410808 0 0 0 LAURA PIZZI CHIEF SCIENCE OFFICER 264808 0 35250 0 0 0 18003 0 38878 0 356939 0 0 0 NANCY S BERG CEO & EXECUTIVE DIRECTOR 257968 0 0 0 0 0 15478 0 5466 0 278912 0 0 0 ELIZABETH LANE CHIEF MARKETING OFFICER 196962 0 18500 0 0 0 12928 0 12599 0 240989 0 0 0 JENNIFER OLSEN-CASILLAS DIRECTOR, MEMBER ENGAGEMENT 188667 0 10483 0 0 0 11949 0 22591 0 233690 0 0 0 MICHELLE ROVNER DIRECTOR, MARKETING 173602 0 16640 0 0 0 11414 0 22591 0 224247 0 0 0 PAUL WONG DIRECTOR, GLOBAL EVENTS 172804 0 24960 0 0 0 11866 0 0 0 209630 0 0 0 JILL CHEN DIRECTOR, FINANCE AND ACCOUNTING 149879 0 5438 0 0 0 7981 0 34442 0 197740 0 0 0 PART I, LINE 7 THE BONUSES WERE PART OF THE ANNUAL BUDGET WHICH WAS APPROVED BY THE BOARD. THESE AMOUNTS REPORTED ON SCHEDULE J, PART II, COLUMN B(II) WERE BASED UPON SEVERAL CRITERIA, SOME WHICH WERE PERFORMANCE-BASED AND SOME WHICH WERE CALCULATED BASED UPON PRE-SET FORMULAS. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE HAS THE DUTIES AND AUTHORITY BETWEEN MEETINGS OF THE BOARD, IN PLACE OF THE BOARD, TO TAKE ACTION ON MATTERS CONSISTENT WITH THE GOALS OF THE SOCIETY. THE EXECUTIVE COMMITTEE IS COMPRISED OF THE OFFICERS OF THE SOCIETY: PRESIDENT, IMMEDIATE PAST PRESIDENT, PRESIDENT-ELECT, EXECUTIVE DIRECTOR (AS SECRETARY) AND TREASURER. THE EXECUTIVE DIRECTOR IS A VOTING MEMBER OF THE BOARD, EXCEPT ON THE MATTER OF THE EXECUTIVE DIRECTOR'S SALARY AND CONTRACT REVIEW AND DETERMINATION. FORM 990, PART VI, SECTION A, LINE 6 THE SOCIETY HAS FIVE TYPES OF MEMBERS AS FOLLOWS: MEMBER - ANY INDIVIDUAL WHO SUPPORTS THE OBJECTIVES OF THE SOCIETY AND IS WILLING TO CONTRIBUTE TO THE ACHIEVEMENT OF THOSE OBJECTIVES IS ELIGIBLE FOR MEMBERSHIP. STUDENT MEMBER - ANY INDIVIDUAL FORMALLY ENROLLED IN A PROGRAM OF STUDY WHICH INCLUDES ASPECTS OF HEALTH ECONOMICS OR HEALTH OUTCOMES RESEARCH IN THE STUDY CURRICULUM AND SUPPORTS THE MISSION OF THE SOCIETY IS ELIGIBLE FOR STUDENT MEMBERSHIP. STUDENT MEMBERS ARE NOT PERMITTED TO HOLD OFFICER OR DIRECTOR POSITIONS. FELLOW - ANY MEMBER WHO IS DEEMED TO HAVE MADE A MERITORIOUS CONTRIBUTION TO THE ADVANCEMENT OF HEALTH ECONOMICS AND/OR OUTCOMES RESEARCH AS DEFINED BY THE ISPOR BOARD. NEW PROFESSIONAL - ANY INDIVIDUAL WITH THREE YEARS OR LESS PROFESSIONAL EXPERIENCE IN HEALTH ECONOMICS OR OUTCOMES RESEARCH. RETIRED MEMBERS - ANY MEMBER WITH TEN OR MORE YEARS OF PAID ISPOR MEMBERSHIP AND WORKING LESS THAN HALF TIME (TWENTY OR FEWER HOURS PER WEEK). FORM 990, PART VI, SECTION A, LINE 7A MEMBERS, STUDENT MEMBERS, FELLOWS, NEW PROFESSIONALS, AND RETIRED MEMBERS HAVE THE RIGHT TO VOTE FOR BOARD OFFICERS AND DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE ISPOR FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. THE REVIEW OF THE FORM 990 BEFORE FILING IS DELEGATED TO THE CEO, EXECUTIVE DIRECTOR, AND DIRECTOR OF FINANCE BY THE BOARD OF DIRECTORS. THE COMPLETED FORM 990 IS AVAILABLE FOR REVIEW BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C TO INSURE COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY, BOARD MEMBERS, OFFICERS AND EMPLOYEES AGREE TO COMPLY WITH THE POLICY BY COMPLETING AND SIGNING A CONFLICT OF INTEREST STATEMENT. EVERY YEAR THE BOARD HAS THE RESPONSIBILITY OF ENSURING COMPLIANCE WITH THE POLICY, ADMINISTERING THE ANNUAL QUESTIONNAIRE AND MAKING DECISIONS AS REQUIRED TO AVOID ACTUAL CONFLICT OF INTEREST. THE BOARD ALSO REVIEWS AND REVISES THIS POLICY AS NEEDED. IN THE EVENT OF AN ACTUAL CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST, THE INTERESTED PARTY MUST DISCLOSE THE NATURE OF THE CONFLICT AND HE/SHE SHALL NOT BE PRESENT IN THE BOARD OR COMMITTEE DELIBERATIONS OR VOTE ON THE MATTER. COMPLETED CONFLICT OF INTEREST FORMS ARE INCLUDED ON BOARD AGENDAS, AND RECORDED IN THE BOARD MINUTES. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, EXCLUDING THE EXECUTIVE DIRECTOR, CONDUCTS AN ANNUAL REVIEW OF THE EXECUTIVE DIRECTOR'S PERFORMANCE INCLUDING ACCOMPLISHMENTS VERSUS PRE-SPECIFIED GOALS AS WELL AS THE PERFORMANCE OF THE ORGANIZATION. BENCHMARKING OF THE COMPENSATION OF THE EXECUTIVE DIRECTOR IS DETERMINED USING ASSOCIATION CHIEF STAFF EXECUTIVE COMPENSATION SURVEYS BY THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES (ASAE). COMPENSATION OF THE EXECUTIVE DIRECTOR IS ALSO DETERMINED WITH THE USE OF COMPENSATION SURVEYS AND THE FORM 990 OF SIMILAR ORGANIZATIONS. THE EXECUTIVE COMMITTEE NEGOTIATES AN EMPLOYMENT AGREEMENT WITH THE EXECUTIVE DIRECTOR AND THEN DETERMINES THE EXECUTIVE DIRECTOR'S COMPENSATION, THROUGH A FORMAL VOTE IN PRIVATE SESSIONS, WITHOUT THE EXECUTIVE DIRECTOR'S PRESENCE. THE FINAL AGREEMENT AND SALARY DETERMINATION IS DOCUMENTED IN A TIMELY COMMUNICATION FROM THE PRESIDENT ON BEHALF OF THE EXECUTIVE COMMITTEE AUTHORIZING THE EXECUTIVE DIRECTOR'S COMPENSATION. THIS COMMUNICATION IS RETAINED WITH THE ISPOR PAYROLL RECORDS. FORM 990, PART VI, SECTION C, LINE 19 ISPOR MAKES ITS FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS AVAILABLE UPON WRITTEN REQUESTS SUBMITTED TO ISPOR'S ADDRESS. ISPOR GLOBAL LLC 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 MANAGMENT COMPANY DE 0 0 THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH INC